Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Progyny (PGNY) Stock Price & Analysis
565 Followers
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.90 - $44.95
Previous Close$27.79
Volume1.17M
Average Volume (3M)1.18M
Market Cap
$2.65B
Enterprise Value$2.29B
Total Cash (Recent Filing)$371.83M
Total Debt (Recent Filing)$16.78M
Price to Earnings (P/E)45.7
Beta1.42
Next Earnings
Aug 01, 2024EPS Estimate
$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.61
Shares Outstanding95,220,688
10 Day Avg. Volume994,712
30 Day Avg. Volume1,177,496
Standard Deviation0.17
R-Squared0.23
Alpha0.00445
Financial Highlights & Ratios
Price to Book (P/B)4.40
Price to Sales (P/S)2.26
Price to Cash Flow (P/CF)23.90
P/FCF Ratio24.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.07
Enterprise Value/Gross Profit9.59
Enterprise Value/Ebitda57.88
Forecast
1Y Price Target
$36.13Price Target Upside30.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Progyny News
PremiumPress Releases
Progyny, Inc. to Host 2024 Inaugural Investor Day
Bulls Say, Bears Say
Bulls Say
Company PerformancePGNY's validated outcomes highlight the benefits of its platform, which is now used by over 450 clients and 6M+ members.
Market OpportunityPGNY is well positioned to continue its strong growth, with half of the self-insured employer market still greenfield, combined with a secular trend towards more equitable and inclusive benefits to better attract and retain employees.
Strategic ExpansionProgyny announced the $5M cash acquisition of Apryl, which is a company with a fertility benefits platform meant to help employees around the world navigate fertility and family building care.
Bears Say
EarningsPGNY reported lower-than-expected revenue for 1Q'24 and missed projections on fertility benefits services revenue.
RegulatoryThe Alabama Supreme Court issued a ruling declaring that embryos outside of the body may be considered children, which has potential negative implications for IVF and other fertility treatments.
UtilizationUtilization concerns for PGNY are amplified due to lower 2024 guidance and below-consensus 2Q guidance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $23.90 and its highest was $44.95 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Aug 01, 2024 which is in 6 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on May 09, 2024. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.132 by $0.038.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.17.
How many shares outstanding does Progyny have?
Progyny has 95,220,690 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.17 in its last earnings report, beating expectations of $0.132. Following the earnings report the stock price went down -15.292%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Farallon Capital Management, L.L.C.. It holds Progyny’s shares valued at 23M.
---
Progyny Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$36.13 (30.01% Upside)
$36.13 (30.01% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 403.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $41.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.90%
12-Months-Change
Fundamentals
Return on Equity
12.30%
Trailing 12-Months
Asset Growth
22.25%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q1 2024
0:00 / 0:00
---
PGNY Stock 12 Month Forecast
Average Price Target
$36.13
▲(30.01% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
5/16 ratings generated profit
1 Year Average Return
-10.84%
reiterated a buy rating 9 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -10.84% per trade.
---